(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PANDEL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PANDEL

ST13

US500000086491499

Class

5

Filing

86491499

Registration

4958246

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

05/18/2025

Trademark type

Word

Nice classes

5

Filing date

12/29/2014

Registration date

05/17/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/19/2022

Last transaction

05/18/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

Tokyo, JP

Examiner

LEASER, ANDREW

Law office

M80

Current location

TMO LAW OFFICE 117

Holders and representatives

Holders

TAISHO PHARMACEUTICAL CO., LTD.

Representatives

Victoria Friedman Dennemeyer & Associates, LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Topical corticosteroid preparations for use as anti-inflammatory agents sold only on prescription

Publications

History of USPTO decisions and trademark events.

29 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/17/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/19/2022

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/19/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/19/2022

E815

TEAS SECTION 8 & 15 RECEIVED

04/20/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/17/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

05/17/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/01/2016

PUBO

PUBLISHED FOR OPPOSITION

03/01/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/10/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/25/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/12/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/06/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/06/2016

ALIE

ASSIGNED TO LIE

01/06/2016

ALIE

ASSIGNED TO LIE

12/28/2015

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

12/17/2015

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

10/07/2015

GNSI

INQUIRY TO SUSPENSION E-MAILED

10/07/2015

CNSI

SUSPENSION INQUIRY WRITTEN

10/07/2015

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/07/2015

GNSL

LETTER OF SUSPENSION E-MAILED

04/07/2015

CNSL

SUSPENSION LETTER WRITTEN

04/07/2015

DOCK

ASSIGNED TO EXAMINER

04/07/2015

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

02/05/2015

ALIE

ASSIGNED TO LIE

01/29/2015

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

01/20/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/08/2015

NWAP

NEW APPLICATION ENTERED

01/01/2015

Continuous trademark protection

Get notified about every new filing that threatens PANDEL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.